Product Information
HALOPERIDOL DEC 100 MG/ML VIAL is a generic product labeled by Mylan Institutional LLC, priced at $15.5981 per ML under NDC 67457040913. Its NADAC has been published 517 times since Nov 12, 2014.
FDA first approved this application on Feb 28, 2000. Its Orange Book therapeutic-equivalence code is AO.
Strength
100 mg/mL
Manufacturer
Mylan Institutional LLCNDC
67457040913
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA075440FDA Approved
2/28/2000
TE Code
AO
On Market Since
3/1/2014
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has been published 517 times since Nov 12, 2014, and over the history we have for it it has declined 61.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.5981 per ML |
|---|---|
| All-time high | $49.2308 (Jan 11, 2017) |
| All-time low | $8.5027 (Jun 22, 2016) |
| 52-week high | $15.5981 |
| 52-week low | $12.9792 |
| Median price | $29.6091 |
| Average price | $29.6110 |
| Largest weekly change | +385.8% (Aug 17, 2016) |
| Weeks tracked | 517 |
| Tracking since | Nov 12, 2014 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol Decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 100 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 100 MG/ML VIAL, manufactured by Mylan Institutional LLC, is $15.5981 per ML (NDC 67457040913), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 100 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has declined 61.0%. It has been tracked across 517 weekly CMS publications since Nov 12, 2014.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 100 MG/ML VIAL?
Since Nov 12, 2014, the NADAC for HALOPERIDOL DEC 100 MG/ML VIAL has ranged from a low of $8.5027 (Jun 22, 2016) to a high of $49.2308 (Jan 11, 2017), with a median of $29.6091 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 100 MG/ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 100 MG/ML VIAL, is $7.5241 per ML — about 52% below HALOPERIDOL DEC 100 MG/ML VIAL.
Who manufactures HALOPERIDOL DEC 100 MG/ML VIAL?
HALOPERIDOL DEC 100 MG/ML VIAL (NDC 67457040913) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.